123I-labeled metaiodobenzylguanidine for diagnosis of neuroendocrine tumors
Lei Jiang1,2, Meike L Schipper1, Peiyong Li2, Zhen Cheng11Molecular Imaging Program at Stanford (MIPS), Departments of Radiology and Bioengineering, Bio-X Program, Stanford University, Stanford, CA, USA; 2Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiaotong University, Shanghai, ChinaA...
Main Authors: | Lei Jiang, Meike L Schipper, Peiyong Li, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-08-01
|
Series: | Reports in Medical Imaging |
Online Access: | http://www.dovepress.com/123i-labeled-metaiodobenzylguanidine-for-diagnosis-of-neuroendocrine-t-a3412 |
Similar Items
-
Neuroendocrine tumors treatment with I-131 Metaiodobenzylguanidine (MIBG)
by: Armaghan Fard-fahani, et al.
Published: (2011-09-01) -
Dosimetry estimation of SPECT/CT for iodine 123-labeled metaiodobenzylguanidine in children
by: Aida Mhiri, et al.
Published: (2015-09-01) -
False Positive Radioiodinated Metaiodobenzylguanidine (123I-MIBG) Uptake in Undifferentiated Adrenal Malignant Tumor
by: Hee Soo Jung, et al.
Published: (2015-01-01) -
Development of an 123I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease
by: Yoshito Kamiya, et al.
Published: (2018-06-01) -
Complete remission of metastatic pheochromocytoma in 123I-metaiodobenzylguanidine scintigraphy after a single session of 131I-metaiodobenzylguanidine therapy: a case report
by: Teruaki Sugino, et al.
Published: (2017-12-01)